The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
EMT Factors and Metabolic Pathways in Cancer
Open accessAbstract
The epithelial-mesenchymal transition (EMT) represents a biological program during which epithelial cells lose their cell identity and acquire a mesenchymal phenotype. EMT is normally observed during organismal development, wound healing and tissue fibrosis. However, this process can be hijacked by cancer cells and is often associated with resistance to apoptosis, acquisition of tissue invasiveness, cancer stem cell characteristics, and cancer treatment resistance. It is becoming evident that EMT is a complex, multifactorial spectrum, often involving episodic, transient or partial events. Multiple factors have been causally implicated in EMT including transcription factors (e.g., SNAIL, TWIST, ZEB), epigenetic modifications, microRNAs (e.g., miR-200 family) and more recently, long non-coding RNAs. However, the relevance of metabolic pathways in EMT is only recently being recognized. Importantly, alterations in key metabolic pathways affect cancer development and progression. In this review, we report the roles of key EMT factors and describe their interactions and interconnectedness. We introduce metabolic pathways that are involved in EMT, including glycolysis, the TCA cycle, lipid and amino acid metabolism, and characterize the relationship between EMT factors and cancer metabolism. Finally, we present therapeutic opportunities involving EMT, with particular focus on cancer metabolic pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–305 of 305
Postigo, A. A., & Dean, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6391 · Cited by 142
The class I bHLH factors E2-2A and E2-2B regulate EMT
Sobrado, V. R., Moreno‐Bueno, G., Cubillo, E., Holt, L. J., Nieto, M. A., Portillo, F., & Cano, A. (2009) · Journal of Cell Science · doi:10.1242/jcs.028241 · Cited by 141
Sun, Y., Daemen, A., Hatzivassiliou, G., Arnott, D. P., WILSON, C. A., Zhuang, G., Gao, M., Liu, P. J., Boudreau, A., Johnson, L., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-20 · Cited by 140
The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients
Blechschmidt, K., Sassen, S., Schmalfeldt, B., Schuster, T., Höfler, H., & Becker, K.-F. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604115 · Cited by 138
Gwak, J. M., Kim, H. J., Kim, E. J., Chung, Y. R., Yun, S., Seo, A. N., Lee, H. J., & Park, S. Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3069-5 · Cited by 136
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonizationPreprint
Takano, S., Reichert, M., Bakir, B. S., Das, K. K., Nishida, T., Miyazaki, M., Heeg, S., Collins, M. A., Marchand, B., Hicks, P. D., et al. (2016) · Genes & Development · doi:10.1101/gad.263327.115 · Cited by 136
Xiao, C., Ch, W., & Hz, H. (2016) · PubMed · Cited by 136
Guo, F., Kerrigan, B. C. P., Yang, D., Hu, L., Ilya Shmulevich, C., Sood, A. K., Xue, F., & Zhang, W. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-19 · Cited by 134
Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis
Xu, Q., Deng, F., Qin, Y., Zhao, Z., Wu, Z., Xing, Z., Ji, A., & Wang, Q. J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.149 · Cited by 133
Topography of epithelial–mesenchymal plasticity
Font-Clos, F., Zapperi, S., & Porta, C. A. M. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722609115 · Cited by 133
Steinway, S. N., Zañudo, J. G. T., Michel, P., Feith, D. J., Loughran, T. P., & Albert, R. (2015) · npj Systems Biology and Applications · doi:10.1038/npjsba.2015.14 · Cited by 132
Grassian, A. R., Lin, F., Barrett, R., Liu, Y., Jiang, W., Korpal, M., Astley, H. M., Gitterman, D. P., Henley, T., Howes, R., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417832 · Cited by 129
Lee, B., VILLARREAL-PONCE, A. P., Fallahi, M., Ovadia, J., Sun, P., Yu, Q., Ito, S., Sinha, S., Nie, Q. H., & Dai, X. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.03.005 · Cited by 128
Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.
Visca, P., Sebastiani, V., Botti, C., Diodoro, M. G., Lasagni, R. P., Romagnoli, F., Brenna, A., de Joannon, B. C., Donnorso, R. P., Lombardi, G., et al. (2004) · PubMed · Cited by 128
Du, S., Guan, Z., Hao, L., Song, Y., Wang, L., Gong, L., Liu, L., Qi, X., Hou, Z., & Shao, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085804 · Cited by 127
Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1.
Liu, C., & Lin, J. (2016) · PubMed · Cited by 127
Crumbs3 Is Essential for Proper Epithelial Development and Viability
Whiteman, E. L., Fan, S., Harder, J. L., Walton, K. D., Liu, C.-J., Soofi, A. A., Fogg, V. C., Hershenson, M. B., Dressler, G. R., Deutsch, G. H., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00999-13 · Cited by 124
LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204.
Li, J., Wang, J., Chen, Y., Li, S., Jin, M., Wang, H., Chen, Z., & Yu, W. (2016) · PubMed · Cited by 123
Gubelmann, C., Schwalie, P. C., Raghav, S. K., Roeder, E., Challa, T. D., Kiehlmann, E., Waszak, S. M., Corsinotti, A., Udin, G., Holcombe, W., et al. (2014) · eLife · doi:10.7554/elife.03346 · Cited by 122
Tsai, S., Chien, I.-H., Shen, W.-H., Kuo, Y.-Z., Jin, Y., Wong, T., Hsiao, J., Wang, H.-P., Shih, N., & Wu, L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.018 · Cited by 122
MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer
Majid, S., Dar, A. A., Saini, S., Deng, G., Chang, I., Greene, K. L., Tanaka, Y., Dahiya, R., & Yamamura, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067686 · Cited by 120
MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
Song, Y., Li, J.-C., Zhu, Y.-H., Dai, Y.-D., Zeng, T., Liu, L., Li, J., Wang, H., Qin, Y.-R., Zeng, M.-S., et al. (2014) · OncoTarget · doi:10.18632/oncotarget.2581 · Cited by 119
Snail family members and cell survival in physiological and pathological cleft palates
Martínez‐Álvarez, C., Blanco, M. J., Pérez-Gómez, R., Rabadán, M. A., Aparicio, M. E., Resel, E., Martı́nez, T., & Nieto, M. A. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.09.022 · Cited by 119
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis
Rupaimoole, R., Lee, J.-H., Hämmerle, M., Ling, H. Y., Previs, R. A., Pradeep, S., Wu, S. Y., Ivan, C., Ferracin, M., Dennison, J. B., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.047 · Cited by 119
Colvin, H. S., Nishida, N., Konno, M., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Kawamoto, K., Asai, A., Tsunekuni, K., et al. (2016) · Scientific Reports · doi:10.1038/srep36289 · Cited by 116
A positive feedback loop bi-stably activates fibroblasts
Yeo, S.-Y., Lee, K.-W., Shin, D., An, S., Cho, K.-H., & Kim, S.-H. (2018) · Nature Communications · doi:10.1038/s41467-018-05274-6 · Cited by 115
A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progressionPreprint
Yu, M., Smolen, G. A., Zhang, J., Wittner, B. S., Schott, B. J., Brachtel, E. F., Ramaswamy, S., Maheswaran, S., & Haber, D. A. (2009) · Genes & Development · doi:10.1101/gad.1809309 · Cited by 115
Oncogenic role of PDK4 in human colon cancer cells
Leclerc, D., Pham, D. N. T., Lévesque, N., Truongcao, M. M., Foulkes, W. D., Sapienza, C., & Rozen, R. R. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.38 · Cited by 115
Reichert, M., Takano, S., von Burstin, J., Kim, S.-B., Lee, J.-S., Ihida-Stansbury, K., Hahn, C., Heeg, S., Schneider, G., Rhim, A. D., et al. (2013) · Genes & Development · doi:10.1101/gad.204453.112 · Cited by 112
The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
Woolbright, B. L., Choudhary, D., Mikhalyuk, A., Trammel, C. J., Shanmugam, S., Abbott, E., Pilbeam, C. C., & Taylor, J. A. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0063 · Cited by 112
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Liu, X., & Gong, Y. (2019) · Biomarker Research · doi:10.1186/s40364-019-0173-z · Cited by 112
Manzo, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00020 · Cited by 110
Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells
Li, J., Dong, L., Wei, D., Wang, X., Zhang, S., & Li, H. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.7357 · Cited by 109
Moya, M., Benet, M., Guzmán, C., Tolosa, L., García‐Monzón, C., Pareja, E., Castell, J. V., & Jover, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030014 · Cited by 108
Small C-terminal Domain Phosphatase Enhances Snail Activity through Dephosphorylation
Wu, Y., Evers, B. M., & Zhou, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806916200 · Cited by 106
KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells
Zhang, H., Liu, L., Wang, Y., Zhao, G., Xie, R., Liu, C., Xiao, X., Wu, K., Nie, Y., Zhang, H., et al. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1363-3 · Cited by 103
Kurahara, H., Takao, S., Maemura, K., Mataki, Y., Kuwahata, T., Maeda, K., Ding, Q., Sakoda, M., Iino, S., Ishigami, S., et al. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.23020 · Cited by 101
Intermediate cell states in epithelial-to-mesenchymal transition
Sha, Y., Haensel, D., Gutierrez, G., Du, H., Dai, X., & Nie, Q. H. (2018) · Physical Biology · doi:10.1088/1478-3975/aaf928 · Cited by 101
Combinatorial Targeting by MicroRNAs Co-ordinates Post-transcriptional Control of EMT
Cursons, J., Pillman, K. A., Scheer, K. G., Gregory, P. A., Foroutan, M., Hediyeh-zadeh, S., Toubia, J., Crampin, E. J., Goodall, G. J., Bracken, C. P., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.019 · Cited by 100
The to and fro of tumour spread
van Denderen, B. J. W., & Thompson, E. W. (2013) · Nature · doi:10.1038/493487a · Cited by 99
PRRX1 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer
Guo, J., Fu, Z., Wei, J., Lü, W., Feng, J., & Zhang, S. (2014) · Medical Oncology · doi:10.1007/s12032-014-0393-x · Cited by 95
Paranjape, A. N., Soundararajan, R., Werden, S. J., Joseph, R., Taube, J. H., Liu, H., Rodriguez‐Canales, J., Sphyris, N., Wistuba, I. I., Miura, N., et al. (2016) · Oncogene · doi:10.1038/onc.2015.498 · Cited by 93
AKT-ions with a TWIST between EMT and MET
Tang, H., Massi, D., Hemmings, B. A., Mandalà, M., Hu, Z., WICKI, A. N., & Xue, G. (2016) · Oncotarget · doi:10.18632/oncotarget.11232 · Cited by 93
Takahashi, Y., Sawada, G., Kurashige, J., Uchi, R., Matsumura, T., Ueo, H., Takano, Y., Akiyoshi, S., Eguchi, H., Sudo, T., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.339 · Cited by 92 · cited 1×
“Paired-related homeobox 1 (PRRX1) overexpression activates EMT in certain cancers, including those of the stomach (127), colorectum (128), pancreas (129) or breast (39), and promotes a migratory and invasive phenotype.”
BackgroundAsparagine and Glutamine: Co-conspirators Fueling Metastasis
Luo, M., Brooks, M. D., & Wicha, M. S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.012 · Cited by 92
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling
Tang, X., Ding, C.-K., Wu, J., Sjol, J., Wardell, S. E., Spasojević, I., George, D. J., McDonnell, D. P., Hsu, D. S., Chang, J. T., et al. (2016) · Oncogene · doi:10.1038/onc.2016.394 · Cited by 87
Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2016) · Oncotarget · doi:10.18632/oncotarget.6879 · Cited by 86
High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer
ZHANG, G.-J., Zhou, T., Tian, H., Liu, Z.-L., & Xia, S. (2012) · Oncology Letters · doi:10.3892/ol.2012.1026 · Cited by 83
SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma
Huang, J., Fan, X.-X., He, J.-X., Pan, H.-D., Li, R.-Z., Huang, L.-Y., Jiang, Z.-B., Yao, X.-J., Liu, L., Leung, E. L.-H., et al. (2016) · OncoTarget · doi:10.18632/oncotarget.9461 · Cited by 82
Cruz-Gil, S., Sánchez‐Martínez, R., de Cedrón, M. G., Martín‐Hernández, R., Vargas, T., Molina, S., Herránz, J., Dávalos, A., Reglero, G., & de Molina, A. R. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m076752 · Cited by 82
ACSL 3 promotes intratumoral steroidogenesis in prostate cancer cells
Migita, T., Takayama, K., Urano, T., Obinata, D., Ikeda, K., Soga, T., Takahashi, S., & Inoue, S. (2017) · Cancer Science · doi:10.1111/cas.13339 · Cited by 81
Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT
Zuo, J., Wen, J., Lei, M., Wen, M., Li, S., Lv, X., Luo, Z., & Wen, G. (2016) · Medical Oncology · doi:10.1007/s12032-015-0716-6 · Cited by 78
Grhl2 reduces invasion and migration through inhibition of TGFβ-induced EMT in gastric cancer
Xiang, J., Fu, X., Ran, W., & Wang, Z. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.83 · Cited by 77
MicroRNA in Lung Cancer Metastasis
Wu, S., Chang, T., Liu, Y., & Shih, J. (2019) · Cancers · doi:10.3390/cancers11020265 · Cited by 74
Mauvoisin, D., Charfi, C., Lounis, M. A., Rassart, É., & Mounier, C. (2012) · Cancer Science · doi:10.1111/cas.12032 · Cited by 73
Sánchez‐Martínez, R., Cruz-Gil, S., García-Álvarez, M. S., Reglero, G., & de Molina, A. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11612-3 · Cited by 73
Du, B., Cawthorn, W. P., Su, A., Doucette, C. R., Yao, Y., Hemati, N., Kampert, S. E., McCoin, C. S., Broome, D. T., Rosen, C. J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.440370 · Cited by 72
HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer
Pudova, E. A., Kudryavtseva, A. V., Fedorova, M., Zaretsky, A. R., Shcherbo, D. S., Lukyanova, E., Popov, A., Садритдинова, А. Ф., Abramov, I. S., Kharitonov, S., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4477-4 · Cited by 71
Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.
Zhong, J., Ogura, K., Wang, Z. P., & Inuzuka, H. (2013) · PubMed · Cited by 70
Funasaka, T., Hu, H., Yanagawa, T., Hogan, V. A., & Raz, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3935 · Cited by 70
Regulation of Epithelial–Mesenchymal Transition through SUMOylation of Transcription Factors
Bogachek, M. V., Andrade, J. P. D., & Weigel, R. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2824 · Cited by 70
Zeb1 affects epithelial cell adhesion by diverting glycosphingolipid metabolism
Mathow, D., Chessa, F., Rabionet, M., Kaden, S., Jennemann, R., Sandhoff, R., Gröne, H., & Feuerborn, A. (2015) · EMBO Reports · doi:10.15252/embr.201439333 · Cited by 69
Røsland, G. V., Dyrstad, S. E., Tusubira, D., Helwa, R., Tan, T. Z., Lotsberg, M. L., Pettersen, I. K. N., Berg, A., Kindt, C. K., Hoel, F., et al. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0197-8 · Cited by 69
Jägle, S., Busch, H. S., Freihen, V., Beyes, S., Schrempp, M., Boerries, M., & Hecht, A. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007109 · Cited by 67
Li, J., Liang, N. N., Long, X., Zhao, J., Yang, J., Du, X., Yang, T., Yuan, P., Huang, X., Zhang, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.001 · Cited by 67
EMT-induced metabolite signature identifies poor clinical outcome
Bhowmik, S. K., Ramirez‐Peña, E., Arnold, J. M., Putluri, V., Sphyris, N., Michailidis, G. C., Putluri, N., Ambs, S., Sreekumar, A., & Mani, S. A. (2015) · Oncotarget · doi:10.18632/oncotarget.4765 · Cited by 66
Prislei, S., Martinelli, E., Zannoni, G. F., Petrillo, M., Filippetti, F., Mariani, M., Mozzetti, S., Raspaglio, G., Scambia, G., & Ferlini, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3943 · Cited by 66
Wilson, K. E., Bachawal, S. V., Tian, L., & Willmann, J. K. (2014) · Theranostics · doi:10.7150/thno.9922 · Cited by 65
TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis
Nuti, S. V., Mor, G., Li, P., & Yin, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2428 · Cited by 64
Lidell, M. E., Seifert, E. L., Westergren, R., Heglind, M., Gowing, A., Sukonina, V., Arani, Z., Itkonen, P., Wallin, S., Westberg, F., et al. (2011) · Diabetes · doi:10.2337/db10-0409 · Cited by 64
Phosphorylation Regulates Functions of ZEB1 Transcription Factor
Llorens, M. C., Hiles, G. L., Cavallo, N. L., Vaglienti, M. V., Perrone, A. P., Carenbauer, A. L., Darling, D. S., & Cabanillas, A. M. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25338 · Cited by 63
Minimal Phenotype of Mice Homozygous for a Null Mutation in the Forkhead/Winged Helix Gene, Mf2
Kume, T., Deng, K.-Y., & Hogan, B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1419-1425.2000 · Cited by 61
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
Drasin, D. J., Guarnieri, A. L., Neelakantan, D., Kim, J., Cabrera, J. H., Wang, C.-A., Zaberezhnyy, V., Gasparini, P., Cascione, L., Huebner, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2394 · Cited by 58
Gras, B., Jacqueroud, L., Wierinckx, A., Lamblot, C., Fauvet, F., Lachuer, J., Puisieux, A., & Ansieau, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092254 · Cited by 58
MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin
Zhang, J., Xu, L., Yang, Z., Lu, H., Da-wei, H., Li, W., Zhang, Z., Liu, B., & Ma, S. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1213-7 · Cited by 58
Chen, G., Zhang, Y., Liang, J., Li, W., Zhu, Y., Zhang, M., Wang, C., & Hou, J. (2018) · BioMed Research International · doi:10.1155/2018/8480762 · Cited by 57
E47 and Id1 Interplay in Epithelial-Mesenchymal Transition
Cubillo, E., Díaz‐López, A., Cuevas, E. P., Moreno‐Bueno, G., Peinado, H., Montes, A., Santos, V., Portillo, F., & Cano, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059948 · Cited by 56
da Fonseca, L. M., da Silva, V. A., Freire‐de‐Lima, L., Previato, J. O., Mendonça‐Previato, L., & Capella, M. A. M. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00158 · Cited by 56
Ovarian cancer and the evolution of subtype classifications using transcriptional profiling†
Cook, D. P., & Vanderhyden, B. C. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz099 · Cited by 56
ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer.
Li, M., Wang, J., Yang, S., Li, W., Xiao, L.-B., He, Y., & Song, X. (2017) · PubMed Central · Cited by 55
Li, C., Zhao, Z., Zhou, Z., & Liu, R. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3931-2 · Cited by 53
Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers
Bruyère, F., Namdarian, B., Corcoran, N. M., Pedersen, J., Ockrim, J., Voelzke, B. B., Mete, U. K., Costello, A. J., & Hovens, C. M. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.11.005 · Cited by 53
Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma
Son, B., Lee, S., Kim, H., Kang, H., Jeon, J., Jo, S., Seong, K. M., Lee, S., Youn, H., & Youn, B. (2019) · Oncogene · doi:10.1038/s41388-019-0974-4 · Cited by 51
Ramirez‐Peña, E., Arnold, J. M., Shivakumar, V., Joseph, R., Vijay, G. V., den Hollander, P., Bhangre, N., Allegakoen, P., Prasad, R., Conley, Z. C., et al. (2019) · Cancers · doi:10.3390/cancers11101610 · Cited by 46
Raza, S., Meyer, M., Schommer, J., Hammer, K. D. P., Guo, B., & Ghribi, O. (2016) · Medical Oncology · doi:10.1007/s12032-015-0725-5 · Cited by 44
Feng, Y., Chen, Y., Xia, L., Lian, J., & Yang, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.123 · Cited by 44
Context Dependency of Epithelial-to-Mesenchymal Transition for Metastasis
Revenco, T., Nicodème, A., Pastushenko, I., Sznurkowska, M. K., Latil, M., Sotiropoulou, P. A., Dubois, C., Moers, V., Lemaire, S., Maertelaer, V. D., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.081 · Cited by 43
Palagani, V., Khatib, M. E., Kossatz-Boehlert, U., Bozko, P. M., Müller, M., Manns, M. P., Krech, T., Malek, N. P., & Plentz, R. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046514 · Cited by 42
An emerging role for class I bHLH E2-2 proteins in EMT regulation and tumor progression
Cano, A., & Portillo, F. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.9995 · Cited by 40
Dobrian, A. D. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00108 · Cited by 39
Lazar, M. A., & Birnbaum, M. J. (2012) · Science · doi:10.1126/science.1221834 · Cited by 38
Kim, S.-J., Chung, T., Choi, H.-J., Kwak, C.-H., Song, K., Suh, S., Kwon, K., Chang, Y., Park, Y., Chang, H. W., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120189 · Cited by 36
Taming Tumor Glycolysis and Potential Implications for Immunotherapy
Ganapathy‐Kanniappan, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00036 · Cited by 36
Liu, B., Han, S., Tang, X., Li, H., & Li, C. (2014) · Oncology Reports · doi:10.3892/or.2014.3119 · Cited by 35
Min, A. L., Choi, J. Y., Woo, H. Y., Kim, J.-D., Kwon, J. H., Bae, S. H., Yoon, S. K., Shin, S. H., Chung, Y. J., & Jung, C. K. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9275-6 · Cited by 35
DeWaal, D. C., Nogueira, V., Terry, A. R., Patra, K. C., Jeon, S., Guzman, G., Au, J., Long, C. P., Antoniewicz, M. R., & Hay, N. (2018) · Nature Communications · doi:10.1038/s41467-018-04182-z · Cited by 33
Prognostic value of ZEB-1 in solid tumors: a meta-analysis
Chen, B., Chen, B., Zhu, Z., Ye, W., Zeng, J., Liu, G., Wang, S., Gao, J., Xu, G., & Huang, Z. (2019) · BMC Cancer · doi:10.1186/s12885-019-5830-y · Cited by 33
Ye, B., Li, Y., Wang, Q., & Xu, C. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9994 · Cited by 30
Twist as a new prognostic marker in hematological malignancies
Norozi, F., Ahmadzadeh, A., Shahjahani, M., Shahrabi, S., & Saki, N. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1357-0 · Cited by 29
ALDOLASE A regulates invasion of bladder cancer cells via E‐cadherin‐EGFR signaling
Li, J., Wang, F., Gao, H., Huang, S., Cai, F., & Sun, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28642 · Cited by 28
Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors
Hsieh, I., Gopula, B., Chou, C., Wu, H.-Y., Chang, G., Wu, W., Chang, C., Chu, P., & Chen, C. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00763 · Cited by 28
Interplay of long non-coding RNAs and TGF/SMAD signaling in different cancers
Farooqı, A. A., Attar, R., Qureshi, M. Z., Fayyaz, S., Sohail, M. I., Sabitaliyevich, U. Y., Nurmurzayevich, S. B., Yelekenova, A. B., Yaylım, İ., & Alaaeddine, N. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2017.64.15.1 · Cited by 17
Zhang, Y., Liao, R., Hu, L.-L., Tong, B.-X., Hao, T., & Wu, H.-J. (2017) · Oncotarget · doi:10.18632/oncotarget.21428 · Cited by 14
Blocking fatty acid synthesis reduces lung tumor growth in mice
Kim, J., & DeBerardinis, R. J. (2016) · Nature Medicine · doi:10.1038/nm.4195 · Cited by 13
Huang, S.-C., Pan, Y., Zhang, Q., & Sun, W. (2019) · Medical Science Monitor · doi:10.12659/msm.913094 · Cited by 11
Cited by
Dynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
Statins: a repurposed drug to fight cancer
Jiang, W., Hu, J.-W., He, X.-R., Jin, W.-L., & He, X.-Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02041-2 · Cited by 417
lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions
McCabe, E. M., & Rasmussen, T. P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.012 · Cited by 312
Tubular Cell Glucose Metabolism Shift During Acute and Chronic Injuries
Faivre, A., Verissimo, T., Auwerx, H., Legouis, D., & de Seigneux, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.742072 · Cited by 64
Metadata
- Authors
- Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V., & Zaravinos, A.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-07
- Volume
- 10
- Pages
- 499-499
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3014456936
- Cited by
- 349
- References
- 305
- FWCI
- 19.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.